Subscribe to Free Daily Newsletters
Post a Job

Featured Jobs

ESOP Consultant

(Atlanta GA / Telecommute)
Retirement Plan Administrator

Group RHI
(Dallas TX / Houston TX / Telecommute)
Project Manager Benefits Communication

BeneCom Associates
(Acton MA / Telecommute)
Client Success Specialist

Ubiquity Retirement + Savings
(AZ / CA / CO / FL / IL / KY / LA / MA / NC / NJ / NV / NY / OR / SC / WA / Telecommute)
Defined Contribution Plan Administrator

The MandMarblestone Group, llc
(Philadelphia PA / Telecommute)
Plan Document Specialist

Aimpoint Pension
(Pompano Beach FL / Telecommute)
Retirement Plan Administrator

Farmer & Betts, Inc.
(Tacoma WA / Littleton CO / Tualatin OR)
Retirement Plan Administration Consultant

(Edina MN / Telecommute)
Sales - 401(k) / DB Administration

Farmer & Betts, Inc.
(Tacoma WA / AL / FL / GA / IA / IL / IN / MD / MN / MO / NC / OH / OK / PA / TN / TX / VA / WI)
Senior Pension Consultant

The Ryding Company
(Westlake Village CA)

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn
Webcasts  >  Upcoming, by Date   |   Recorded
Conferences  >  Upcoming, by Date   |   Upcoming, by State
Combined  >  Upcoming, by Date   |   Recorded or Upcoming, by Sponsor

View More EBRI [Employee Benefit Research Institute] Webcasts and Conferences

Cost Differences for Oncology Medicines Based on Site of Treatment

EBRI [Employee Benefit Research Institute]

Feb. 26, 2020
3 p.m. ET

A new study from the Employee Benefit Research Institute (EBRI) Center for Research on Health Benefits Innovation, finds payments for infused cancer medicines in the commercial and employment-based markets are nearly two times higher in hospital outpatient departments (HOPD), relative to physician offices (PO), for the same drug. The Issue Brief, “Cost Differences for Oncology Medicines Based on Site of Treatment”, also finds these cost differences are due to the pricing decisions of hospitals, not differences in modality.

EBRI invites you to a webinar that will address these findings, explore actions that employers and third-party payers can take to lower patient costs, and more.   

Continue by clicking on the following link:

© 2020, Inc.